Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy

scientific article published on 10 April 2017

Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.UROLONC.2017.03.015
P932PMC publication ID5545055
P698PubMed publication ID28408295

P50authorDarren R FeldmanQ56588360
Daniel M TennenbaumQ57543592
P2093author name stringMaria E Arcila
Jonathan A Coleman
Almedina Redzematovic
Paul Russo
James J Hsieh
Martin H Voss
Robert J Motzer
Nicole E Benfante
Maria I Carlo
Abraham Ari Hakimi
Brandon J Manley
Jozefina Casuscelli
Maria F Becerra
Nabeela Khan
Emily Zabor
P2860cites workCorrelation Between Molecular Subclassifications of Clear Cell Renal Cell Carcinoma and Targeted Therapy Response.Q39445282
The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional samplingQ42737907
VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400.Q43455466
Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma.Q43806776
A clear picture of renal cell carcinomaQ45674698
Variation in genomic landscape of clear cell renal cell carcinoma across Europe.Q51019551
Prognostic Value of SETD2 Expression in Patients with Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors.Q54170263
Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma.Q55122666
Wild-type VHL Clear Cell Renal Cell Carcinomas Are a Distinct Clinical and Histologic Entity: A 10-Year Follow-upQ88555345
Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validationQ27852038
Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research networkQ27852242
Comprehensive molecular characterization of clear cell renal cell carcinomaQ27852374
Integrated molecular analysis of clear-cell renal cell carcinomaQ27852382
Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter studyQ33510317
BAP1 loss defines a new class of renal cell carcinomaQ34280223
Prognostic factors for survival in previously treated patients with metastatic renal cell carcinomaQ34293726
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular OncologyQ35584856
Gender Specific Mutation Incidence and Survival Associations in Clear Cell Renal Cell Carcinoma (CCRCC).Q35814190
The Global Burden of Cancer 2013Q35847426
Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinomaQ36365688
High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinomaQ36373524
Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinomaQ36736210
VHL gene mutations in renal cell carcinoma: role as a biomarker of disease outcome and drug efficacyQ37393004
Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression.Q37573538
BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapiesQ38545726
P433issue8
P921main subjectrenal cell carcinomaQ1164529
P304page(s)532.e7-532.e13
P577publication date2017-04-10
P1433published inUrologic OncologyQ2113446
P1476titleGenomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy
P478volume35

Reverse relations

cites work (P2860)
Q92412551Combining molecular and imaging metrics in cancer: radiogenomics
Q92372097Molecular Classification of Renal Cell Carcinoma and Its Implication in Future Clinical Practice
Q92154621Prognostic and Predictive Value of PBRM1 in Clear Cell Renal Cell Carcinoma
Q90319417Redefining the Role of Surgical Management of Metastatic Renal Cell Carcinoma
Q64977645Whole-Exome Sequencing Identifies Somatic Mutations Associated With Mortality in Metastatic Clear Cell Kidney Carcinoma.

Search more.